The chromatin landscape of Kaposi's sarcoma-associated herpesvirus

Viruses

Volumn 5, Issue 5, 2013, Pages 1346-1373

  Toth, Zsolt ^a   Brulois, Kevin ^a   Jung, Jae U ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

EZH2; Histone modifications; JMJD2A; Kaposi's sarcoma associated herpesvirus; KS; KSHV; Minichromosome; MLL Set1; Polycomb; Viral chromatin

Indexed keywords

MICRORNA;

CHROMATIN STRUCTURE; DEACETYLATION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION REGULATION; HISTONE ACETYLATION; HISTONE CODE; HUMAN; HUMAN HERPESVIRUS 8; NONHUMAN; NUCLEAR REPROGRAMMING; REVIEW; TRANSCRIPTOMICS; VIRUS GENOME; VIRUS LATENCY; VIRUS PATHOGENESIS;

CHROMATIN; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84878209277     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5051346     Document Type: Review

References (123)

1. Cesarman, E.; Moore, P.S.; Rao, P.H.; Inghirami, G.; Knowles, D.M.; Chang, Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995, 86, 2708-2714.
2. Chang, Y.; Cesarman, E.; Pessin, M.S.; Lee, F.; Culpepper, J.; Knowles, D.M.; Moore, P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266, 1865-1869.
3. Lu, C.; Zeng, Y.; Huang, Z.; Huang, L.; Qian, C.; Tang, G.; Qin, D. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus. Am. J. Pathol. 2005, 166, 173-183.
4. Merat, R.; Amara, A.; Lebbe, C.; de The, H.; Morel, P.; Saib, A. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation. Int. J. Canc. 2002, 97, 791-795.
5. Mercader, M.; Taddeo, B.; Panella, J.R.; Chandran, B.; Nickoloff, B.J.; Foreman, K.E. Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am. J. Pathol. 2000, 156, 1961-1971.
6. Vieira, J.; O'Hearn, P.; Kimball, L.; Chandran, B.; Corey, L. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J. Virol. 2001, 75, 1378-1386.
7. Ye, F.; Zhou, F.; Bedolla, R.G.; Jones, T.; Lei, X.; Kang, T.; Guadalupe, M.; Gao, S.J. Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog. 2011, 7, e1002054.
8. Davis, D.A.; Rinderknecht, A.S.; Zoeteweij, J.P.; Aoki, Y.; Read-Connole, E.L.; Tosato, G.; Blauvelt, A.; Yarchoan, R. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 2001, 97, 3244-3250.
9. Russo, J.J.; Bohenzky, R.A.; Chien, M.C.; Chen, J.; Yan, M.; Maddalena, D.; Parry, J.P.; Peruzzi, D.; Edelman, I.S.; Chang, Y.; et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 1996, 93, 14862-14867.
10. Jenner, R.G.; Alba, M.M.; Boshoff, C.; Kellam, P. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol. 2001, 75, 891-902.
11. Chen, J.; Ueda, K.; Sakakibara, S.; Okuno, T.; Parravicini, C.; Corbellino, M.; Yamanishi, K. Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc. Natl. Acad. Sci. USA 2001, 98, 4119-4124.
12. Lu, F.; Zhou, J.; Wiedmer, A.; Madden, K.; Yuan, Y.; Lieberman, P.M. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J. Virol. 2003, 77, 11425-11435.
13. Xie, J.; Ajibade, A.O.; Ye, F.; Kuhne, K.; Gao, S.J. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology 2008, 371, 139-154.
14. Ballestas, M.E.; Chatis, P.A.; Kaye, K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 1999, 284, 641-644.
15. Renne, R.; Lagunoff, M.; Zhong, W.; Ganem, D. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol. 1996, 70, 8151-8154.
16. Zentner, G.E.; Henikoff, S. Regulation of nucleosome dynamics by histone modifications. Nat. Struct. Mol. Biol. 2013, 20, 259-266.
17. Yun, M.; Wu, J.; Workman, J.L.; Li, B. Readers of histone modifications. Cell Res. 2011, 21, 564-578.
18. Cedar, H.; Bergman, Y. Programming of DNA methylation patterns. Annu. Rev. Biochem. 2012, 81, 97-117.
19. Loyola, A.; Almouzni, G. Marking histone H3 variants: How, when and why? Trends Biochem. Sci. 2007, 32, 425-433.
20. Holwerda, S.; de Laat, W. Chromatin loops, gene positioning, and gene expression. Front. Genet. 2012, 3, e217.
21. Grundhoff, A.; Ganem, D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 2004, 113, 124-136.
22. Krishnan, H.H.; Naranatt, P.P.; Smith, M.S.; Zeng, L.; Bloomer, C.; Chandran, B. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 2004, 78, 3601-3620.
23. Guito, J.; Lukac, D.M. KSHV Rta promoter specification and viral reactivation. Front. Microbiol. 2012, 3, e30.
24. Gwack, Y.; Baek, H.J.; Nakamura, H.; Lee, S.H.; Meisterernst, M.; Roeder, R.G.; Jung, J.U. Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation. Mol. Cell. Biol. 2003, 23, 2055-2067.
25. Budt, M.; Hristozova, T.; Hille, G.; Berger, K.; Brune, W. Construction of a lytically replicating Kaposi's sarcoma-associated herpesvirus. J. Virol. 2011, 85, 10415-10420.
26. Lu, F.; Tsai, K.; Chen, H.S.; Wikramasinghe, P.; Davuluri, R.V.; Showe, L.; Domsic, J.; Marmorstein, R.; Lieberman, P.M. Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA. J. Virol. 2012, 86, 5752-5762.
27. Campbell, M.; Chang, P.C.; Huerta, S.; Izumiya, C.; Davis, R.; Tepper, C.G.; Kim, K.Y.; Shevchenko, B.; Wang, D.H.; Jung, J.U.; et al. Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen. J. Biol. Chem. 2012, 287, 5806-5818.
28. Barbera, A.J.; Chodaparambil, J.V.; Kelley-Clarke, B.; Luger, K.; Kaye, K.M. Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome. Cell Cycle 2006, 5, 1048-1052.
29. Lu, F.; Day, L.; Gao, S.J.; Lieberman, P.M. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. J. Virol. 2006, 80, 5273-5282.
30. Li, Q.; Zhou, F.; Ye, F.; Gao, S.J. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology 2008, 379, 234-244.
31. Matsumura, S.; Persson, L.M.; Wong, L.; Wilson, A.C. The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains. J. Virol. 2010, 84, 2318-2330.
32. Shamay, M.; Krithivas, A.; Zhang, J.; Hayward, S.D. Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc. Natl. Acad. Sci. USA 2006, 103, 14554-14559.
33. Sakakibara, S.; Ueda, K.; Nishimura, K.; Do, E.; Ohsaki, E.; Okuno, T.; Yamanishi, K. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J. Virol. 2004, 78, 7299-7310.
34. Viejo-Borbolla, A.; Kati, E.; Sheldon, J.A.; Nathan, K.; Mattsson, K.; Szekely, L.; Schulz, T.F. A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin. J. Virol. 2003, 77, 7093-7100.
35. Lim, C.; Lee, D.; Seo, T.; Choi, C.; Choe, J. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. J. Biol. Chem. 2003, 278, 7397-7405.
36. Krithivas, A.; Young, D.B.; Liao, G.; Greene, D.; Hayward, S.D. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J. Virol. 2000, 74, 9637-9645.
37. Lim, C.; Gwack, Y.; Hwang, S.; Kim, S.; Choe, J. The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 2001, 276, 31016-31022.
38. Lim, C.; Sohn, H.; Lee, D.; Gwack, Y.; Choe, J. Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J. Virol. 2002, 76, 10320-10331.
39. Cotter, M.A., 2nd; Robertson, E.S. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 1999, 264, 254-264.
40. Stedman, W.; Deng, Z.; Lu, F.; Lieberman, P.M. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J. Virol. 2004, 78, 12566-12575.
41. Ye, F.C.; Zhou, F.C.; Yoo, S.M.; Xie, J.P.; Browning, P.J.; Gao, S.J. Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J. Virol. 2004, 78, 11121-11129.
42. Xiao, B.; Verma, S.C.; Cai, Q.; Kaul, R.; Lu, J.; Saha, A.; Robertson, E.S. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores. J. Virol. 2010, 84, 9718-9732.
43. Si, H.; Verma, S.C.; Lampson, M.A.; Cai, Q.; Robertson, E.S. Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation. J. Virol. 2008, 82, 6734-6746.
44. Ottinger, M.; Christalla, T.; Nathan, K.; Brinkmann, M.M.; Viejo-Borbolla, A.; Schulz, T.F. Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest. J. Virol. 2006, 80, 10772-10786.
45. Barbera, A.J.; Chodaparambil, J.V.; Kelley-Clarke, B.; Joukov, V.; Walter, J.C.; Luger, K.; Kaye, K.M. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 2006, 311, 856-861.
46. Viejo-Borbolla, A.; Ottinger, M.; Bruning, E.; Burger, A.; Konig, R.; Kati, E.; Sheldon, J.A.; Schulz, T.F. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J. Virol. 2005, 79, 13618-13629.
47. Krithivas, A.; Fujimuro, M.; Weidner, M.; Young, D.B.; Hayward, S.D. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 2002, 76, 11596-11604.
48. Cheng, F.; Weidner-Glunde, M.; Varjosalo, M.; Rainio, E.M.; Lehtonen, A.; Schulz, T.F.; Koskinen, P.J.; Taipale, J.; Ojala, P.M. KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA. PLoS Pathog. 2009, 5, e1000324.
49. Woodard, C.; Shamay, M.; Liao, G.; Zhu, J.; Ng, A.N.; Li, R.; Newman, R.; Rho, H.S.; Hu, J.; Wan, J.; et al. Phosphorylation of the chromatin binding domain of KSHV LANA. PLoS Pathog. 2012, 8, e1002972.
50. Toth, Z.; Maglinte, D.T.; Lee, S.H.; Lee, H.R.; Wong, L.Y.; Brulois, K.F.; Lee, S.; Buckley, J.D.; Laird, P.W.; Marquez, V.E.; et al. Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog. 2010, 6, e1001013.
51. Gunther, T.; Grundhoff, A. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 2010, 6, e1000935.
52. Toth, Z.; Brulois, K.F.; Wong, L.Y.; Lee, H.R.; Chung, B.; Jung, J.U. Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression. J. Virol. 2012, 86, 9696-9707.
53. Wu, T.T.; Park, T.; Kim, H.; Tran, T.; Tong, L.; Martinez-Guzman, D.; Reyes, N.; Deng, H.; Sun, R. ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J. Virol. 2009, 83, 2265-2273.
54. Wong, E.; Wu, T.T.; Reyes, N.; Deng, H.; Sun, R. Murine gammaherpesvirus 68 open reading frame 24 is required for late gene expression after DNA replication. J. Virol. 2007, 81, 6761-6764.
55. Arumugaswami, V.; Wu, T.T.; Martinez-Guzman, D.; Jia, Q.; Deng, H.; Reyes, N.; Sun, R. ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J. Virol. 2006, 80, 9730-9740.
56. Simon, J.A.; Kingston, R.E. Mechanisms of polycomb gene silencing: Knowns and unknowns. Nat. Rev. Mol. Cell Biol 2009, 10, 697-708.
57. Stock, J.K.; Giadrossi, S.; Casanova, M.; Brookes, E.; Vidal, M.; Koseki, H.; Brockdorff, N.; Fisher, A.G.; Pombo, A. Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat. Cell Biol. 2007, 9, 1428-1435.
58. Francis, N.J.; Kingston, R.E.; Woodcock, C.L. Chromatin compaction by a polycomb group protein complex. Science 2004, 306, 1574-1577.
59. Dellino, G.I.; Schwartz, Y.B.; Farkas, G.; McCabe, D.; Elgin, S.C.; Pirrotta, V. Polycomb silencing blocks transcription initiation. Mol. Cell 2004, 13, 887-893.
60. Pasini, D.; Hansen, K.H.; Christensen, J.; Agger, K.; Cloos, P.A.; Helin, K. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes Dev. 2008, 22, 1345-1355.
61. Mills, A.A. Throwing the cancer switch: Reciprocal roles of polycomb and trithorax proteins. Nat. Rev. Cancer 2010, 10, 669-682.
62. Raaphorst, F.M. Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors. Hum. Mol. Genet. 2005, 14, R93-R100.
63. Margueron, R.; Justin, N.; Ohno, K.; Sharpe, M.L.; Son, J.; Drury, W.J., 3rd; Voigt, P.; Martin, S.R.; Taylor, W.R.; De Marco V.; et al. Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 2009, 461, 762-767.
64. Hansen, K.H.; Bracken, A.P.; Pasini, D.; Dietrich, N.; Gehani, S.S.; Monrad, A.; Rappsilber, J.; Lerdrup, M.; Helin, K. A model for transmission of the H3K27me3 epigenetic mark. Nat. Cell Biol. 2008, 10, 1291-1300.
65. Gao, Z.; Zhang, J.; Bonasio, R.; Strino, F.; Sawai, A.; Parisi, F.; Kluger, Y.; Reinberg, D. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol. Cell. 2012, 45, 344-356.
66. Tavares, L.; Dimitrova, E.; Oxley, D.; Webster, J.; Poot, R.; Demmers, J.; Bezstarosti, K.; Taylor, S.; Ura, H.; Koide, H.; et al. RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Cell 2012, 148, 664-678.
67. Kwiatkowski, D.L.; Thompson, H.W.; Bloom, D.C. The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency. J. Virol. 2009, 83, 8173-8181.
68. Cliffe, A.R.; Garber, D.A.; Knipe, D.M. Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters. J. Virol. 2009, 83, 8182-8190.
69. Pasini, D.; Malatesta, M.; Jung, H.R.; Walfridsson, J.; Willer, A.; Olsson, L.; Skotte, J.; Wutz, A.; Porse, B.; Jensen O.N.; et al. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res. 2010, 38, 4958-4969.
70. Smith, E.R.; Lee, M.G.; Winter, B.; Droz, N.M.; Eissenberg, J.C.; Shiekhattar, R.; Shilatifard, A. Drosophila UTX is a histone H3 Lys27 demethylase that colocalizes with the elongating form of RNA polymerase II. Mol. Cell Biol. 2008, 28, 1041-1046.
71. Lee, M.G.; Villa, R.; Trojer, P.; Norman, J.; Yan, K.P.; Reinberg, D.; Di Croce, L.; Shiekhattar, R. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 2007, 318, 447-450.
72. Ernst, P.; Wang, J.; Huang, M.; Goodman, R.H.; Korsmeyer, S.J. MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Mol. Cell Biol. 2001, 21, 2249-2258.
73. Rossetto, C.C.; Pari, G. KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome. PLoS Pathog. 2012, 8, e1002680.
74. Toth, Z.; Jung, J. University of Southern California, Los Angeles, CA, USA. Unpublished work, 2013.
75. Reynolds, N.; Salmon-Divon, M.; Dvinge, H.; Hynes-Allen, A.; Balasooriya, G.; Leaford, D.; Behrens, A.; Bertone, P.; Hendrich, B. NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression. EMBO J. 2012, 31, 593-605.
76. van der Vlag, J.; Otte, A.P. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat. Genet. 1999, 23, 474-478.
77. Chang, P.C.; Fitzgerald, L.D.; Hsia, D.A.; Izumiya, Y.; Wu, C.Y.; Hsieh, W.P.; Lin, S.F.; Campbell, M.; Lam, K.S.; Luciw, P.A.; et al. Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor. J. Virol. 2011, 85, 3283-3293.
78. Fritsch, L.; Robin, P.; Mathieu, J.R.; Souidi, M.; Hinaux, H.; Rougeulle, C.; Harel-Bellan, A.; Ameyar-Zazoua, M.; Ait-Si-Ali, S. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol. Cell 2010, 37, 46-56.
79. Chang, P.C.; Fitzgerald, L.D.; Van Geelen, A.; Izumiya, Y.; Ellison, T.J.; Wang, D.H.; Ann, D.K.; Luciw, P.A.; Kung, H.J. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase. Canc. Res. 2009, 69, 5681-5689.
80. Kim, K.Y.; Huerta, S.B.; Izumiya, C.; Wang, D.H.; Martinez, A.; Shevchenko, B.; Kung, H.J.; Campbell, M.; Izumiya, Y. Kaposi's Sarcoma-Associated Herpesvirus (KSHV) latency associated nuclear antigen regulates KSHV epigenome by association with histone demethylase, KDM3A. J. Virol. 2013, doi:10.1128/JVI.00011-13.
81. Lefort, S.; Gravel, A.; Flamand, L. Repression of interferon-alpha stimulated genes expression by Kaposi's sarcoma-associated herpesvirus K-bZIP protein. Virology 2010, 408, 14-30.
82. Miller, T.; Krogan, N.J.; Dover, J.; Erdjument-Bromage, H.; Tempst, P.; Johnston, M.; Greenblatt, J.F.; Shilatifard, A. COMPASS: A complex of proteins associated with a trithorax-related SET domain protein. Proc. Natl. Acad. Sci. USA 2001, 98, 12902-12907.
83. Briggs, S.D.; Bryk, M.; Strahl, B.D.; Cheung, W.L.; Davie, J.K.; Dent, S.Y.; Winston, F.; Allis, C.D. Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae. Genes Dev. 2001, 15, 3286-3295.
84. Shilatifard, A. The COMPASS family of histone H3K4 methylases: Mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 2012, 81, 65-95.
85. Wang, P.; Lin, C.; Smith, E.R.; Guo, H.; Sanderson, B.W.; Wu, M.; Gogol, M.; Alexander, T.; Seidel, C.; Wiedemann, L.M.; et al. Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol. Cell Biol. 2009, 29, 6074-6085.
86. Wu, M.; Wang, P.F.; Lee, J.S.; Martin-Brown, S.; Florens, L.; Washburn, M.; Shilatifard, A. Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS. Mol. Cell Biol. 2008, 28, 7337-7344.
87. Krivtsov, A.V.; Armstrong, S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Canc. 2007, 7, 823-833.
88. Jong, J.E.; Cha, S.; Jang, J.H.; Seo, T. Alteration of histone H3 lysine 4 trimethylation on putative lytic gene promoters by human Set1 complex during reactivation of Kaposi's Sarcoma-Associated Herpesvirus. Intervirology 2013, 56, 91-103.
89. Kim, J.; Guermah, M.; McGinty, R.K.; Lee, J.S.; Tang, Z.; Milne, T.A.; Shilatifard, A.; Muir, T.W.; Roeder, R.G. RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 2009, 137, 459-471.
90. Gallinari, P.; di Marco, S.; Jones, P.; Pallaoro, M.; Steinkuhler, C. HDACs, histone deacetylation and gene transcription: From molecular biology to cancer therapeutics. Cell Res. 2007, 17, 195-211.
91. Sterner, D.E.; Berger, S.L. Acetylation of histones and transcription-related factors. Microbiol Mol. Biol. Rev. 2000, 64, 435-459.
92. Wang, S.E.; Wu, F.Y.; Chen, H.; Shamay, M.; Zheng, Q.; Hayward, G.S. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J. Virol. 2004, 78, 4248-4267.
93. Wang, S.E.; Wu, F.Y.; Fujimuro, M.; Zong, J.; Hayward, S.D.; Hayward, G.S. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP. J. Virol. 2003, 77, 600-623.
94. Ye, J.; Shedd, D.; Miller, G. An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate. J. Virol. 2005, 79, 1397-1408.
95. Jones, P.A. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 2012, 13, 484-492.
96. Jin, B.; Li, Y.; Robertson, K.D. DNA methylation: Superior or subordinate in the epigenetic hierarchy? Genes Canc. 2011, 2, 607-617.
97. Denis, H.; Ndlovu, M.N.; Fuks, F. Regulation of mammalian DNA methyltransferases: A route to new mechanisms. EMBO Rep. 2011, 12, 647-656.
98. Szekely, L.; Kiss, C.; Mattsson, K.; Kashuba, E.; Pokrovskaja, K.; Juhasz, A.; Holmvall, P.; Klein, G. Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin-associated nuclear bodies. J. Gen. Virol. 1999, 80, 2889-2900.
99. Kang, H.; Wiedmer, A.; Yuan, Y.; Robertson, E.; Lieberman, P.M. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathog. 2011, 7, e1002140.
100. Stedman, W.; Kang, H.; Lin, S.; Kissil, J.L.; Bartolomei, M.S.; Lieberman, P.M. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J. 2008, 27, 654-666.
101. Chen, H.S.; Wikramasinghe, P.; Showe, L.; Lieberman, P.M. Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency. J. Virol. 2012, 86, 9454-9464.
102. Kang, H.; Cho, H.; Sung, G.H.; Lieberman, P.M. CTCF regulates Kaposi's Sarcoma-Associated Herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming. J. Virol. 2013, 87, 1789-1799.
103. Kang, H.; Lieberman, P.M. Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: Disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion. J. Virol. 2011, 85, 11159-11169.
104. Darst, R.P.; Haecker, I.; Pardo, C.E.; Renne, R.; Kladde, M.P. Epigenetic diversity of Kaposi's sarcoma-associated herpesvirus. Nucleic Acids Res. 2013, 41, 2993-3009.
105. Wang, H.W.; Trotter, M.W.; Lagos, D.; Bourboulia, D.; Henderson, S.; Makinen, T.; Elliman, S.; Flanagan, A.M.; Alitalo, K.; Boshoff, C. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 2004, 36, 687-693.
106. Hong, Y.K.; Foreman, K.; Shin, J.W.; Hirakawa, S.; Curry, C.L.; Sage, D.R.; Libermann, T.; Dezube, B.J.; Fingeroth, J.D.; Detmar, M. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat. Genet. 2004, 36, 683-685.
107. Cheng, F.; Pekkonen, P.; Laurinavicius, S.; Sugiyama, N.; Henderson, S.; Gunther, T.; Rantanen, V.; Kaivanto, E.; Aavikko, M.; Sarek, G.; et al. KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. Cell Host Microbe 2011, 10, 577-590.
108. Hansen, A.; Henderson, S.; Lagos, D.; Nikitenko, L.; Coulter, E.; Roberts, S.; Gratrix, F.; Plaisance, K.; Renne, R.; Bower, M.; et al. KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev. 2010, 24, 195-205.
109. Di Bartolo, D.L.; Cannon, M.; Liu, Y.F.; Renne, R.; Chadburn, A.; Boshoff, C.; Cesarman, E. KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood 2008, 111, 4731-4740.
110. Qin, Z.; Jakymiw, A.; Findlay, V.; Parsons, C. KSHV-encoded MicroRNAs: Lessons for viral cancer pathogenesis and emerging concepts. Int. J. Cell Biol. 2012, 2012, 603961.
111. Dahlke, C.; Maul, K.; Christalla, T.; Walz, N.; Schult, P.; Stocking, C.; Grundhoff, A. A microRNA encoded by Kaposi sarcoma-associated herpesvirus promotes B-cell expansion in vivo. PLoS One 2012, 7, e49435.
112. Lu, F.; Stedman, W.; Yousef, M.; Renne, R.; Lieberman, P.M. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J. Virol. 2010, 84, 2697-2706.
113. Rossetto, C.C.; Tarrant-Elorza, M.; Verma, S.; Purushothaman, P.; Pari, G.S. Regulation of viral and cellular gene expression by Kaposi's sarcoma associated herpesvirus (KSHV) PAN RNA. J. Virol. 2013, 87, 5540-5553.
114. Hwang, S.; Gwack, Y.; Byun, H.; Lim, C.; Choe, J. The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription. J. Virol. 2001, 75, 9509-9516.
115. Li, M.; Damania, B.; Alvarez, X.; Ogryzko, V.; Ozato, K.; Jung, J.U. Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol. Cell Biol. 2000, 20, 8254-8263.
116. He, M.; Zhang, W.; Bakken, T.; Schutten, M.; Toth, Z.; Jung, J.U.; Gill, P.; Cannon, M.; Gao, S.J. Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2. Canc. Res. 2012, 72, 3582-3592.
117. Arguello, M.; Sgarbanti, M.; Hernandez, E.; Mamane, Y.; Sharma, S.; Servant, M.; Lin, R.; Hiscott, J. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene 2003, 22, 964-973.
118. Jha, H.C.; Upadhyay, S.K.; Aj, M.P.; Lu, J.; Cai, Q.; Saha, A.; Robertson, E.S. H2AX phosphorylation is important for LANA mediated KSHV episome persistence. J. Virol. 2013, 87, 5255-5269.
119. Dillon, P.J.; Gregory, S.M.; Tamburro, K.; Sanders, M.K.; Johnson, G.L.; Raab-Traub, N.; Dittmer, D.P.; Damania, B. Tousled-like kinases modulate reactivation of gammaherpesviruses from latency. Cell Host Microbe 2013, 13, 204-214.
120. Tan, M.; Luo, H.; Lee, S.; Jin, F.; Yang, J.S.; Montellier, E.; Buchou, T.; Cheng, Z.; Rousseaux, S.; Rajagopal, N.; et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011, 146, 1016-1028.
121. Liang, Y.; Vogel, J.L.; Arbuckle, J.H.; Rai, G.; Jadhav, A.; Simeonov, A.; Maloney, D.J.; Kristie, T.M. Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency. Sci. Transl. Med. 2013, 5, 167ra165.
122. Liang, Y.; Quenelle, D.; Vogel, J.L.; Mascaro, C.; Ortega, A.; Kristie, T.M. A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency. MBio 2013, 4, e00558-12.
123. Liang, Y.; Vogel, J.L.; Narayanan, A.; Peng, H.; Kristie, T.M. Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat. Med. 2009, 15, 1312-1317.